Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Evotec (NASDAQ:EVO) through any online brokerage.
Other companies in Evotec’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Illumina Inc (NASDAQ:ILMN).
Evotec has a consensus price target of $4.93.
The stock price for Evotec (NASDAQ: EVO) is $1.64 last updated October 2, 2026 at 7:02 AM EDT.
There are no upcoming dividends for Evotec.
Evotec does not have any upcoming earnings scheduled.
There is no upcoming split for Evotec.
Evotec is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.